153 related articles for article (PubMed ID: 7060486)
1. [Subcutaneous application of heparin with a jet injector (author's transl)].
Harenberg J; Arleth D; Köppern K; Matthes K; Zimmermann R
Dtsch Med Wochenschr; 1982 Apr; 107(13):497-500. PubMed ID: 7060486
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a jet injection system in administering morphine and heparin to healthy adults.
Baer CL; Bennett WM; Folwick DA; Erickson RS
Am J Crit Care; 1996 Jan; 5(1):42-8. PubMed ID: 8680492
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of subcutaneous heparin in the prevention of thrombo-embolism after major hip operations (author's transl)].
Schöndorf TH; Hey D
Dtsch Med Wochenschr; 1975 Oct; 100(40):2014-8. PubMed ID: 1157717
[TBL] [Abstract][Full Text] [Related]
4. [Parameters of hemostasis during treatments associating fractionated heparin administered subcutaneously to standard and fractionated heparin administered intravenously in the chronic hemodialysis patient].
Morinière P; Diéval J; Roussel B; Gross S; Bayrou B; Delobel J; Fournier A
Nephrologie; 1990; 11(3):141-6. PubMed ID: 2234270
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of postoperative thrombo-embolic accidents following thoracic surgery by low-dose calcium heparinate: a comparative study (author's transl)].
Le Brigand H; Morille P; Garnier B; Bogaty-Yver J; Samama M; Spriet A
Sem Hop; 1981 May 18-25; 57(19-20):972-7. PubMed ID: 6266028
[TBL] [Abstract][Full Text] [Related]
6. [Effect of low-molecular heparin on blood coagulation].
Harenberg J; de Vries JX; Weber E; Zimmermann R
Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448
[TBL] [Abstract][Full Text] [Related]
7. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
[TBL] [Abstract][Full Text] [Related]
8. Postoperative thrombosis prophylaxis with subcutaneous heparin-Ca injection.
Adám J
Ther Hung; 1990; 38(3):133-6. PubMed ID: 2284623
[TBL] [Abstract][Full Text] [Related]
9. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium].
Briel RC
Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of thromboembolism using subcutaneous heparin].
Saggau W; Encke A; Schmidt U
Chirurg; 1974 Sep; 45(9):407-9. PubMed ID: 4425325
[No Abstract] [Full Text] [Related]
11. Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism).
Collignon F; Frydman A; Caplain H; Ozoux ML; Le Roux Y; Bouthier J; Thébault JJ
Thromb Haemost; 1995 Apr; 73(4):630-40. PubMed ID: 7495071
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
[TBL] [Abstract][Full Text] [Related]
14. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
Greene CE; Meriwether E
Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative thromboembolism: preventive use of calcium heparin in low doses].
Di Laura I; Capellaro L; Giammarinaro A
Minerva Med; 1985 Feb; 76(5):153-61. PubMed ID: 3974928
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
Kearon C
Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of thromboembolism in hysterectomies with low molecular weight heparin Fragmin].
Briel RC; Doller P; Hermann CP
Geburtshilfe Frauenheilkd; 1988 Mar; 48(3):160-4. PubMed ID: 2836259
[TBL] [Abstract][Full Text] [Related]
19. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
[TBL] [Abstract][Full Text] [Related]
20. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
Schott G
Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
